For the quarter ending 2026-03-31, SUPN has $1,500,725K in assets. $423,920K in debts. $184,869K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 184,869 | 128,448 | 151,371 | 144,711 |
| Marketable securities | 199,372 | 180,222 | 129,789 | 377,885 |
| Accounts receivable, net | 182,183 | 187,802 | 171,254 | 140,831 |
| Inventories, net | 87,062 | 82,385 | 79,399 | 44,023 |
| Prepaid expenses and other current assets | 78,094 | 65,325 | 62,078 | 31,416 |
| Total current assets | 731,580 | 644,182 | 593,891 | 738,866 |
| Restricted cash | 1,450 | 1,450 | 1,450 | - |
| Property and equipment, net | 10,042 | 10,531 | 10,627 | 11,069 |
| Intangible assets, net | 549,712 | 569,456 | 623,481 | 481,307 |
| Goodwill | 120,668 | 124,882 | 119,080 | 117,019 |
| Deferred income tax assets, net | 30,820 | 38,351 | 8,793 | 6,181 |
| Other assets | 56,453 | 63,796 | 62,432 | 27,963 |
| Total assets | 1,500,725 | 1,452,648 | 1,419,754 | 1,382,405 |
| Accounts payable and accrued liabilities | 101,244 | 107,800 | 108,613 | 77,739 |
| Accrued product returns and rebates | 189,720 | 161,097 | 184,459 | 180,916 |
| Contingent consideration, current portion | 0 | 31,052 | 11,235 | 0 |
| Other current liabilities | 82,965 | 38,222 | 26,322 | 27,705 |
| Total current liabilities | 373,929 | 338,171 | 330,629 | 286,360 |
| Contingent consideration, long-term | 206 | 206 | 213 | - |
| Operating lease liabilities, long-term | 30,267 | 30,365 | 31,422 | 24,383 |
| Deferred income tax liabilities, net | - | 0 | 0 | 0 |
| Other liabilities | 19,518 | 22,192 | 7,823 | 7,762 |
| Total liabilities | 423,920 | 390,934 | 370,087 | 318,505 |
| Common stock, 0.001 par value 130,000,000 shares authorized 58,039,721 and 57,457,462 shares issued and outstanding as of march 31, 2026 and december31, 2025, respectively | 58 | 57 | 57 | 56 |
| Additional paid-in capital | 561,419 | 543,825 | 527,700 | 496,946 |
| Accumulated other comprehensive loss, net of tax | -255 | -44 | -71 | -200 |
| Retained earnings | 515,583 | 517,876 | 521,981 | 567,098 |
| Total stockholders' equity | 1,076,805 | 1,061,714 | 1,049,667 | 1,063,900 |
| Total liabilities and stockholders' equity | 1,500,725 | 1,452,648 | 1,419,754 | 1,382,405 |
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
SUPERNUS PHARMACEUTICALS, INC. (SUPN)